Tony Cárdenas: “Biosimilars hold the potential to help cut down these costs with…”

On the recordMarch 12, 2019

Biosimilars hold the potential to help cut down these costs with marketed biosimilars being priced an average of 40 percent less than the biologic.

Said by

Democratic · California

Source

Highlighting the cost-saving potential of biosimilars.

More from Tony Cárdenas

Mar 27, 2023

There are real abuses right now on the part of social media companies not only in America but around the world.

Mar 28, 2023

9-8-8 is, in fact, a big step in the right direction.

Apr 18, 2023

Affordable broadband to every American is far from over. We have a lot of work to do.

Mar 22, 2023

Are you investing more and more and more every day into bringing down that kind of content? That is my question. Are you?

Other voices in this conversation

Tony Cárdenas: “Biosimilars hold the potential to help cut down these costs with marketed biosimilars being priced an average of 40…”